Skip to main content.

Yellow Fever

History, Epidemiology, and Vaccination Information

Page

Go to the Home page

Go to Main Menu

Go to Previous page

Go to Next page

Exit the course

Section Menu

Yellow Fever Vaccines

Administration

Things to Consider

Adverse Events

Mild Adverse Events

Severe Reactions

Hypersensitivity Reactions

Neurologic Disease

Viscerotropic Disease

Question 2

Monitoring Patients

Contraindications and Precautions

Hypersensitivity Reactions

Less severe forms of immediate hypersensitivity reactions can occur, including rash or urticaria. Yellow fever vaccine can rarely cause anaphylaxis. The Vaccine Adverse Event Reporting System (VAERS) data from 2000–2006 indicate a reporting rate for anaphylaxis of 1.8 cases per 100,000 doses administered.

Hypersensitivity reactions are thought to occur in response to egg protein, chicken protein, or gelatin that are present in the vaccine as a result of the production process. Also, the stopper of the vaccine vial contains dry natural latex rubber that may cause an allergic reaction.

 

Because anaphylaxis has been reported to occur in people with no prior history of reactions to the vaccine components, all yellow fever vaccine recipients should be observed for at least 15 minutes following vaccination. All providers administering the vaccine should be prepared to rapidly recognize and treat this life-threatening reaction. Injectable epinephrine and equipment for maintaining an airway should be available for immediate use, in accordance with the General Recommendations of the ACIP.